Early identification and standardization of clinical diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation. The platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs.
Treatment and management of the treatment for Pompe disease delay requires individualized development, typically including drug therapy, rehabilitation intervention, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of late onset of Pompé disease. The platform serves a team of domestic and foreign experts in the field of neural systems related to the China International Medical Service System, providing the following services to patients: 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.